SZSE Ticker: 002014

Huangshan Novel Co., Ltd.

黄山永新股份有限公司

永新股份

NOVEL

Listing Date: 2004-07-08

Board: SME

Industry Classification: Manufacturing

Zhongsheng Pharmaceutical was investigated by 13 institutions: Fufang Xueshuantong Capsule and Naoshuantong Capsule strengthened evidence-based evidence through medical research and obtained high-quality clinical research results (with survey questions and answers)

Post date May 20, 2022 — 16:00 Post Lock

Kexing, Chengye Inactivation-Titanium Media Official Website

Post date May 17, 2022 — 17:15 Post Lock

One word down! Important shareholders of popular infrastructure stocks plan to reduce their holdings, after 11 daily limit in 14 days

Post date May 17, 2022 — 15:32 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of second-degree speculation in risk concept stocks_Sina Finance_Sina.com

Post date May 17, 2022 — 15:02 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network

Post date May 17, 2022 — 14:57 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

Post date May 17, 2022 — 14:10 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

Post date May 17, 2022 — 12:42 Post Lock

One word down! Important shareholders of popular infrastructure stocks plan to reduce their holdings, after 11 daily limit in 14 days-

Post date May 17, 2022 — 12:40 Post Lock

Many pharmaceutical companies clarified that the concept stock of Qianjintansu was on fire! Patent inventor responds to controversy with live broadcast_Oriental Fortune Network

Post date May 17, 2022 — 11:15 Post Lock

Qianjintansu concept stocks are on fire, and many pharmaceutical companies have clarified! Patent inventor responds to controversy with live broadcast in China Xinhua

Post date May 17, 2022 — 09:47 Post Lock

The inventor of the patent related to fenugreek: the fluctuation of the secondary market has nothing to do with us_Oriental Fortune Net

Post date May 17, 2022 — 09:36 Post Lock

Qianjintansu concept stocks are on fire, and many pharmaceutical companies have clarified! The patent inventor responded live to the disputed Yunnan Baiyao injection.

Post date May 17, 2022 — 09:14 Post Lock

Jiuqiang Bio: The company's novel coronavirus (2019-nCOV) antigen detection kit (latex method) product has obtained EU CE access qualification

Post date May 17, 2022 — 07:06 Post Lock

The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang

Post date May 17, 2022 — 04:08 Post Lock

The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it

Post date May 17, 2022 — 02:08 Post Lock

The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm

Post date May 17, 2022 — 02:06 Post Lock

"False positive" on the hot search, the company manager once reviewed that he did not earn enough

Post date May 16, 2022 — 23:51 Post Lock

After Lianhua Qingwen came to Qianjinvine again? Seedlings have risen tenfold, and the secondary market is carnival. Who is "Li Kui" and who is "Li Gui"? -Finance-financial world

Post date May 16, 2022 — 23:05 Post Lock

After Lianhua Qingwen came to Qianjinvine again? Seedlings have risen tenfold, the secondary market is carnival, who is "Li Kui" and who is "Li Gui"

Post date May 16, 2022 — 23:05 Post Lock

Green Valley Pharma's Phase 9-1 overseas clinical trial terminated, how difficult is it to develop Alzheimer's disease drugs

Post date May 16, 2022 — 21:32 Post Lock

Want to see more data? Registered subscribers can see all the data.